Joanne Kurtzberg | Professor Of Pediatrics And Pathology; Director, Marcus Center For Cellular Cures,
Duke University Medical Center

Joanne Kurtzberg, Professor Of Pediatrics And Pathology; Director, Marcus Center For Cellular Cures,, Duke University Medical Center

Dr. Joanne Kurtzberg is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplantation, umbilical cord blood banking and transplantation, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine. Dr. Kurtzberg pioneered the use of umbilical cord blood as an alternative stem cell source for unrelated hematopoietic stem cell transplantation (HSCT). Over the last two decades Dr. Kurtzberg has established an internationally known pediatric transplant program at Duke which treats children with cancer, blood disorders, immune deficiencies, hemoglobinopathies and inherited metabolic diseases. In 2010, Kurtzberg established the Julian Robertson Cell and Translational Therapy Program (CT2) at Duke. CT2 focuses on translational studies from bench to bedside with a focus on bringing cellular therapies in regenerative medicine to the clinic. Recent areas of investigation in CT2 include the use of autologous cord blood in children with autism spectrum disorder, neonatal brain injury and cerebral palsy, as well as preclinical studies manufacturing oligodendrocyte-like cells from cord blood to treat patients with acquired and genetic brain diseases. Studies of autologous bone marrow ALDHbright cells in adults with stroke and radiation induced brain injury are also underway.


Day 1: Wednesday 19th May 2021 - Cell Therapy @ 16:30

Cord blood and cord tissue derived cellular therapies for pediatric brain diseases

  • Discuss differences between cord blood and cord tissue cells and their roles in potential treatment of pediatric brain injuries.
  • Update results of ongoing studies of cord blood therapies in children with cerebral palsy and autism
  • Update results of ongoing studies with cord tissue MSCs in children with autism, babies with HIE

Day 1: Wednesday 19th May 2021 - Cell Therapy @ 17:00

Roundtable: The future of cord blood use. Business models, new uses for CB, ethics of pioneering new trials, updating the delivery room

·A poll will be taken to learn more about the people who are interested in CB, to learn about their activities in the CB field, and we will show the statistical results in the event and even discuss them
last published: 10/May/21 08:45 GMT

back to speakers